BUZZ-Amicus Therapeutics: On track to report trial data

Mon Jun 30, 2014 10:35am EDT

** The drugmaker's shares up 28 pct at $3.88

** Says on track to report data from a late-stage trial of its genetic disorder drug in the third quarter of this year